Fresenius and WuXi Biologics Sign Biosimilar Pipeline Agreement
Fresenius said it signed an agreement with WuXi Biologics covering a biosimilar development pipeline.
Related stories
Iberdrola Adds 274 MW Tmega Wind Project to Alliance Portfolio
A new closing adds the 274 MW Tmega wind project to the alliance portfolio, expanding its assets to more than 1,800 MW.
M impact | EQUITY | Nov 02, 2026, 07:35 AM UTC
SK Securities Plans KRW 10 Billion Equity-Linked Bond Offering
SK Securities plans an equity-linked bond offering worth KRW 10 billion.
L impact | EQUITY | Nov 02, 2026, 07:34 AM UTC
Mare Group Agrees to Acquire 60% of ASS.EL.
Mare Group has signed an agreement to acquire a 60% stake in ASS.EL.
M impact | EQUITY | Nov 02, 2026, 07:34 AM UTC
Mare Group Agrees to Acquire a Stake in ASS.EL.
Mare Group agreed to acquire a stake in ASS.EL.
M impact | EQUITY | Nov 02, 2026, 07:34 AM UTC
Elmera Applies for Delisting
L impact | EQUITY | Nov 02, 2026, 07:33 AM UTC
ADD Properties Signs $265 Million Financing for Giza Grand Hyatt Hotel
ADD Properties signed a $265 million syndicated financing agreement to support a 400-key Grand Hyatt hotel overlooking the Grand Egyptian Museum and reprofile its capital structure
M impact | EQUITY | Nov 02, 2026, 07:33 AM UTC